MediSpend completed the acquisition of Real Life Sciences.

MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, completed the acquisition of Real Life Sciences, an advanced anonymization solutions provider for clinical trial and other data. Financial terms were not disclosed. "Real Life Sciences' innovative solutions align perfectly with MediSpend's mission to empower life sciences companies with technology that drives growth, compliance and transparency. This acquisition expands the company's reach into research and development (R&D) compliance and the protection of vital intellectual property as well as enhances our ability to serve a broader market and support our clients with tools to meet evolving global regulatory demands," Leigh Powell, MediSpend Executive Chairman.